Abby Care raised an $82 million Series C led by Transformation Capital to fund a model in which family members…
Oxford-based OMass Therapeutics has raised $310 million in Series C financing, the second-largest private biotech round in Europe this year.
BigHat's Milliner platform pairs frontier models with automated lab work, and its first antibody-drug conjugate is now in patients.
The San Francisco insurer raised $200M in Series C equity and completed a $400M tender offer at a $2.7B valuation.
Archy's Series C brings total funding to $97M as its agents take over dental billing, charting and scheduling.
AI agents that steer prescriptions past insurance and pharmacy hurdles earn Forus a $3B valuation.
The AI biotech startup triples its valuation in eight months with backing from Lilly, Pfizer and Novartis partnerships.